# The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma

> **NCT05106179** · PHASE4 · UNKNOWN · sponsor: **Center for Vascular Pathology, Moscow** · enrollment: 1000 (estimated)

## Conditions studied

- Spinal Tumor
- Spinal Hemangioma
- Beta Blocker Toxicity

## Interventions

- **DRUG:** Atenolol Pill
- **DRUG:** Propranolol Pill

## Key facts

- **NCT ID:** NCT05106179
- **Lead sponsor:** Center for Vascular Pathology, Moscow
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12
- **Primary completion:** 2022-12
- **Final completion:** 2023-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2021-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05106179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05106179, "The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05106179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*